Patent details

EP2216026 Title: Ophthalmic compositions and uses for treating ophthalmic conditions

Basic Information

Publication number:
EP2216026
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101542215
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Ophthalmic compositions and uses for treating ophthalmic conditions
French Title of Invention:
Compositions ophthalmologiques et leur utilisation pour le traitement des maladies oculaires.
German Title of Invention:
Ophthalmologische Zusammensetzungen und deren Verwendung zur Behandlung von Augenkrankheiten
SPC Number:

Dates

Filing date:
11/07/2005
Grant date:
20/04/2016
EP Publication Date:
20/04/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/08/2010
EP B1 Publication Date:
20/04/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/07/2016
Expiration date:
11/07/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/07/2005
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

Name:
Whitcup Scott M.
Address:
United States (US)

Priority

Priority Number:
587092
Priority Date:
12/07/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/573;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages